Latest 10-K annual reports

Newbury Street II Acquisition Corp's Form 10-K filing details the company's registered securities as of December 31, 2024, including units, Class A Ordinary Shares, and public warrants.

General Enterprise Ventures, Inc. (GEVI) reports increased revenue for 2024 driven by commercialization of its CitroTech products, but continues to experience net losses and relies on debt financing.

Longevity Health Holdings, Inc. reports its 2024 financial results, highlighting a strategic shift towards bio-aesthetics and addressing concerns about its ability to continue as a going concern.

Spruce Power's 2024 10-K filing reveals a year of strategic acquisitions and operational improvements amidst financial challenges and regulatory scrutiny.

SolarMax Technology reports a significant revenue decline, a substantial net loss, and ongoing concerns about its ability to continue as a going concern, alongside identified material weaknesses in its internal controls.

Abercrombie & Fitch Co. files its 10-K report, highlighting a successful fiscal year with significant sales growth and strategic initiatives for future expansion.

Talphera, Inc.'s FY 2024 10-K filing reveals ongoing financial losses and a need for additional capital, balanced by progress in product development and strategic divestments.

Klotho Neurosciences enters into a securities purchase agreement for \$2.17 million via senior convertible notes and warrants to fund general corporate purposes.

Actinium Pharmaceuticals' 2024 annual report details the company's financial results, pipeline advancements, and strategic focus on targeted radiotherapies for advanced cancers.

Valuence Merger Corp. I reports its annual results on Form 10-K, highlighting its ongoing efforts to find a suitable business combination target amidst challenges including a Nasdaq delisting and limited operational runway.

Celcuity Inc.'s 10-K filing provides a detailed overview of its capital stock structure, outstanding warrants, and measures in place to deter potential takeovers as of December 31, 2024.

Freeze Tag, Inc. reports a net loss of $492,605 for 2024 and is exploring strategic options due to increased costs of being a public company.

BT Brands saw a revenue increase in 2024, driven by acquisitions and same-store sales growth, but also experienced a larger net loss due to impairment charges and increased operating costs.

Sachem Capital Corp. reports a net loss for 2024 due to various factors, including realized losses on loan sales and increased provisions for credit losses, while also addressing covenant compliance issues and strategic shifts.

NexPoint Capital, Inc. releases its 10-K filing, detailing investment activities and financial performance for the year ended December 31, 2024, highlighting a portfolio of middle-market healthcare and other sector investments.

T1 Energy Inc. completed the acquisition of Trina Solar's U.S. assets, initiated solar module production, and advanced plans for a U.S. solar cell manufacturing facility in 2024, marking a significant shift towards integrated U.S.-based solar manufacturing.

Yotta Acquisition Corporation's 10-K filing reveals substantial doubt about its ability to continue as a going concern, despite entering a merger agreement with DRIVEiT Financial Auto Group, due to an approaching deadline for completing a business combination and material weaknesses in internal controls.

LGL Group's 2024 10-K filing reveals increased revenues driven by electronic instruments and strategic investments, offset by higher expenses and a potential capital raise.

MDB Capital Holdings reports its FY2024 financial results, highlighting the deconsolidation of eXoZymes, strategic shifts in operations, and ongoing efforts to strengthen internal controls.

Seritage Growth Properties reports its 10-K filing, highlighting ongoing asset sales and strategic plan execution amid challenging market conditions.

Microvast Holdings, Inc. announces a 24% increase in revenue for 2024, but grapples with funding delays for its Clarksville, Tennessee facility and identifies a material weakness in internal controls.

Knightscope's 2024 annual report highlights continued losses, strategic restructuring, and a focus on expanding its market presence in public safety technology.

High Wire Networks' 2024 annual report reveals continued losses despite a modest increase in revenue and strategic moves to divest and restructure operations.

NexPoint Diversified Real Estate Trust's 2024 10-K filing reveals a year of strategic shifts, including the NHT acquisition, amid mixed financial performance and plans for asset reallocation.

OmniQ Corp.'s 2024 revenues decreased by 9% to $73.6 million, with a net loss of $10 million, as the company focuses on operational excellence and strategic acquisitions.

LFTD Partners Inc.'s 10-K filing reveals recurring losses, regulatory challenges, and significant financial obligations, raising concerns about its ability to continue as a going concern.

Calidi Biotherapeutics outlines its capital structure, clinical trial progress, and regulatory landscape in its annual 10-K filing, highlighting both opportunities and challenges for its novel immuno-oncology platforms.

byNordic Acquisition Corporation's latest 10-K filing reveals delisting from Nasdaq, ongoing efforts to secure a business combination amidst financial constraints, and a looming deadline for liquidation.

Scientific Industries reports a decrease in net loss for fiscal year 2024, driven by cost reductions in its Bioprocessing Systems operations, while navigating challenges in its Benchtop Laboratory Equipment segment.

Nu-Med Plus, Inc. files its Form 10-K for the year ended December 31, 2024, reporting a net loss and highlighting substantial doubt about its ability to continue as a going concern without additional funding.